Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020;18(12):1213-1226.
doi: 10.2174/1570159X18666200914162013.

The Effects and Underlying Mechanisms of Cell Therapy on Blood-Brain Barrier Integrity After Ischemic Stroke

Affiliations

The Effects and Underlying Mechanisms of Cell Therapy on Blood-Brain Barrier Integrity After Ischemic Stroke

Li Gao et al. Curr Neuropharmacol. 2020.

Abstract

Ischemic stroke is one of the main causes of mortality and disability worldwide. However, efficient therapeutic strategies are still lacking. Stem/progenitor cell-based therapy, with its vigorous advantages, has emerged as a promising tool for the treatment of ischemic stroke. The mechanisms involve new neural cells and neuronal circuitry formation, antioxidation, inflammation alleviation, angiogenesis, and neurogenesis promotion. In the past decades, in-depth studies have suggested that cell therapy could promote vascular stabilization and decrease blood-brain barrier (BBB) leakage after ischemic stroke. However, the effects and underlying mechanisms on BBB integrity induced by the engrafted cells in ischemic stroke have not been reviewed yet. Herein, we will update the progress in research on the effects of cell therapy on BBB integrity after ischemic stroke and review the underlying mechanisms. First, we will present an overview of BBB dysfunction under the ischemic condition and cells engraftment for ischemic treatment. Then, we will summarize and discuss the current knowledge about the effects and underlying mechanisms of cell therapy on BBB integrity after ischemic stroke. In particular, we will review the most recent studies in regard to the relationship between cell therapy and BBB in tissue plasminogen activator (t-PA)-mediated therapy and diabetic stroke.

Keywords: Ischemic stroke; blood-brain barrier; neurogenesis; stem cells; tissue plasminogen activator.

PubMed Disclaimer

Figures

Fig (1)
Fig (1)
The schematic diagram of the neurovascular unit and tight junctions. (A) The NVU comprises endothelial cells, pericytes, astrocytes that can interact with neurons, perivascular macrophages/microglia and other brain components to impart specific properties on the BBB. (B) The endothelial TJs include interacting transmembrane proteins Claudins, Occludins, and JAMs, as well as auxiliary cytoplasmic proteins ZO proteins. (A higher resolution / colour version of this figure is available in the electronic copy of the article).

Similar articles

Cited by

References

    1. Marei H.E., Hasan A., Rizzi R., Althani A., Afifi N., Cenciarelli C., Caceci T., Shuaib A. Potential of stem cell-based therapy for ischemic stroke. Front. Neurol. 2018;9:34. doi: 10.3389/fneur.2018.00034. - DOI - PMC - PubMed
    1. Sarmah D., Kaur H., Saraf J., Pravalika K., Goswami A., Kalia K., Borah A., Wang X., Dave K.R., Yavagal D.R., Bhattacharya P. Getting closer to an effective intervention of ischemic stroke: the big promise of stem cell. Transl. Stroke Res. 2018;9(4):356–374. doi: 10.1007/s12975-017-0580-0. - DOI - PubMed
    1. Borlongan C.V., Lind J.G., Dillon-Carter O., Yu G., Hadman M., Cheng C., Carroll J., Hess D.C. Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats. Brain Res. 2004;1010(1-2):108–116. doi: 10.1016/j.brainres.2004.02.072. - DOI - PubMed
    1. Zacharek A., Chen J., Cui X., Li A., Li Y., Roberts C., Feng Y., Gao Q., Chopp M. Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J. Cereb. Blood Flow Metab. 2007;27(10):1684–1691. doi: 10.1038/sj.jcbfm.9600475. - DOI - PMC - PubMed
    1. Lalu M.M., Montroy J., Dowlatshahi D., Hutton B., Juneau P., Wesch N., Zhang Y. S.; McGinn, R.; Corbett, D.; Stewart, D.J.A.; A Fergusson, D. From the lab to patients: a systematic review and meta-analysis of mesenchymal stem cell therapy for stroke. Transl. Stroke Res. 2020;11(3):345–364. doi: 10.1007/s12975-019-00736-5. - DOI - PubMed

Substances